Literature DB >> 23216527

Infected prosthetic dialysis arteriovenous grafts: a single dialysis center study.

Petr Bachleda1, Lucie Kalinova, Petr Utikal, Milan Kolar, Kristyna Hricova, Tatana Stosova.   

Abstract

BACKGROUND: The prosthetic arteriovenous grafts (AVG) being used increasingly to create hemodialysis access are prone to infections that pose potentially life-threatening infectious and bleeding complications, as well as loss of dialysis access. In this study, we identified the bacteriologic agents of infected AVGs by site swab, blood culture, and prosthesis cultures, and to evaluate the role of microbiological findings in the management of the infection.
METHODS: We focused on 51 patients with 53 AVGs operated on in our clinic from January 2006 to December 2009. An infected AVG was identified by clinical, ultrasound, and microbiological findings. Sensitivity to antibiotics was determined for all bacterial strains. Isolates were identified by pulsed-field gel electrophoresis (PFGE) of bacterial DNA. In a few cases, positron emission tomography-computed tomography (PET-CT) examination was performed.
RESULTS: Strains of Staphylococcus spp., especially S. aureus, were the most frequent cause of infected AVG. All S. aureus strains were sensitive to methicillin. With the exception of a single case, isolates obtained simultaneously from the skin site and the vascular prosthesis were identical genetically.
CONCLUSIONS: Our results suggest that bacterial infectious agents detected in site swab, blood, or graft culture confirm a suspicion of AVG infection. A PET-CT examination can provide confirmation. The combination of microbiologic and radionuclide findings can improve the management of the AVG infection, but surgery remains essential.

Entities:  

Mesh:

Year:  2012        PMID: 23216527      PMCID: PMC3532001          DOI: 10.1089/sur.2011.041

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  29 in total

1.  III. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: update 2000.

Authors: 
Journal:  Am J Kidney Dis       Date:  2001-01       Impact factor: 8.860

2.  Linezolid breakpoints.

Authors: 
Journal:  Clin Microbiol Infect       Date:  2001-05       Impact factor: 8.067

3.  Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus.

Authors:  Duarte C Oliveira; Hermínia de Lencastre
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

4.  Clinical consequences of infected arteriovenous grafts in hemodialysis patients.

Authors:  T E Minga; K H Flanagan; M Allon
Journal:  Am J Kidney Dis       Date:  2001-11       Impact factor: 8.860

5.  Staphylococcus aureus and other bacteremias in hemodialysis patients: antibiotic therapy and surgical removal of access site.

Authors:  J R Lentino; L M Baddour; M Wray; E S Wong; V L Yu
Journal:  Infection       Date:  2000 Nov-Dec       Impact factor: 3.553

6.  Mortality caused by sepsis in patients with end-stage renal disease compared with the general population.

Authors:  M J Sarnak; B L Jaber
Journal:  Kidney Int       Date:  2000-10       Impact factor: 10.612

7.  Hemodialysis vascular access preferences and outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Authors:  Eric W Young; Dawn M Dykstra; David A Goodkin; Donna L Mapes; Robert A Wolfe; Philip J Held
Journal:  Kidney Int       Date:  2002-06       Impact factor: 10.612

8.  Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: predicting the impact of NKF-DOQI clinical practice guidelines for vascular access.

Authors:  Kurt B Stevenson; Elizabeth L Hannah; Connie A Lowder; Michael J Adcox; Robert L Davidson; Michael C Mallea; Nagraj Narasimhan; Jon P Wagnild
Journal:  Am J Kidney Dis       Date:  2002-03       Impact factor: 8.860

Review 9.  Infection with antimicrobial-resistant microorganisms in dialysis patients.

Authors:  Jeffrey S Berns
Journal:  Semin Dial       Date:  2003 Jan-Feb       Impact factor: 3.455

10.  Arteriovenous fistulae vs. arteriovenous grafts: a retrospective review of 1,700 consecutive vascular access cases.

Authors:  A F Schild; E Perez; E Gillaspie; C Seaver; J Livingstone; A Thibonnier
Journal:  J Vasc Access       Date:  2008 Oct-Dec       Impact factor: 2.283

View more
  4 in total

1.  Small-diameter artery decellularization: Effects of anionic detergent concentration and treatment duration on porcine internal thoracic arteries.

Authors:  Colton Kostelnik; Julia Hohn; Carlos E Escoto-Diaz; Jesse B Kooistra; Matthew Stern; Derrick E Swinton; William Richardson; Wayne Carver; John Eberth
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2021-12-02       Impact factor: 3.368

Review 2.  Tissue engineering: Relevance to neonatal congenital heart disease.

Authors:  Kevin M Blum; Gabriel J M Mirhaidari; Christopher K Breuer
Journal:  Semin Fetal Neonatal Med       Date:  2021-02-27       Impact factor: 3.726

3.  Sustained release of vancomycin from novel biodegradable nanofiber-loaded vascular prosthetic grafts: in vitro and in vivo study.

Authors:  Kuo-Sheng Liu; Cheng-Hung Lee; Yi-Chuan Wang; Shih-Jung Liu
Journal:  Int J Nanomedicine       Date:  2015-01-29

4.  Surgical management of an infected external iliac artery interposition graft with a bioengineered human acellular vessel.

Authors:  Christy Guth; Thomas Naslund
Journal:  J Vasc Surg Cases Innov Tech       Date:  2021-10-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.